Monografie
Applied immunopeptidomics - identification and characterization of novel targets for the immunotherapy of ovarian cancer = Angewandte Immunopeptidomik - Identifikation und Charakterisierung neuer immuntherapeutischer Targets für das Ovarialkarzinom
- Sprache
-
Englisch
- Umfang
-
186 Seiten, 46 ungezählte Seiten
- Identifier
-
1079607870
Thema
Hochschulschrift
Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Der Zugriff auf Teile des Objekts ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.04.2024, 08:50 MESZ
Objekttyp
- Monografie
Ähnliche Objekte (12)
Identification and functional characterization of novel cancer targets in mutant KRAS-driven malignancies
p16INK4a as target for T cell-based cancer immunotherapy
Identification of potential targets for palbociclib combination therapy in the context of MLL-rearranged acute myeloid leukemia
Nanoparticle-triggered TRL4-mediated pro-inflammatory approach for cancer immunotherapy
Identification and validation of ENTPD5 as a novel target gene of mutant p53 in cancer
Large-scale analysis of kinase inhibitors' target binding kinetics : implications for drug discovery?
Identification of RNA interference screening derived cancer cell viability signatures as a source of novel anti-tumor targets
Mikrobielle Genomik, angewandte Bioinformatik und die Evolution der Mikroorganismen
Identification and characterization of the novel SREBP target C17orf59
Towards novel targets for receptor-mediated nanoparticle delivery
Identification of novel breast and ovarian cancer susceptibility genes by hypothesis-driven and exome-wide approaches
Molecular targets of head & neck cancer for radiosensitization and immunotherapy : rapidly accelerated fibrosarcoma (RAF) signaling, epidermal growth factor receptor, human papillomavirus, and cancer-testis antigens
Identification and functional characterization of novel cancer targets in mutant KRAS-driven malignancies
p16INK4a as target for T cell-based cancer immunotherapy
Identification of potential targets for palbociclib combination therapy in the context of MLL-rearranged acute myeloid leukemia
Nanoparticle-triggered TRL4-mediated pro-inflammatory approach for cancer immunotherapy
Identification and validation of ENTPD5 as a novel target gene of mutant p53 in cancer
Large-scale analysis of kinase inhibitors' target binding kinetics : implications for drug discovery?
Identification of RNA interference screening derived cancer cell viability signatures as a source of novel anti-tumor targets
Mikrobielle Genomik, angewandte Bioinformatik und die Evolution der Mikroorganismen
Identification and characterization of the novel SREBP target C17orf59
Towards novel targets for receptor-mediated nanoparticle delivery
Identification of novel breast and ovarian cancer susceptibility genes by hypothesis-driven and exome-wide approaches
Molecular targets of head & neck cancer for radiosensitization and immunotherapy : rapidly accelerated fibrosarcoma (RAF) signaling, epidermal growth factor receptor, human papillomavirus, and cancer-testis antigens
Identification and functional characterization of novel cancer targets in mutant KRAS-driven malignancies
p16INK4a as target for T cell-based cancer immunotherapy
Identification of potential targets for palbociclib combination therapy in the context of MLL-rearranged acute myeloid leukemia
Nanoparticle-triggered TRL4-mediated pro-inflammatory approach for cancer immunotherapy
Identification and validation of ENTPD5 as a novel target gene of mutant p53 in cancer
Large-scale analysis of kinase inhibitors' target binding kinetics : implications for drug discovery?
Identification of RNA interference screening derived cancer cell viability signatures as a source of novel anti-tumor targets
Mikrobielle Genomik, angewandte Bioinformatik und die Evolution der Mikroorganismen
Identification and characterization of the novel SREBP target C17orf59
Towards novel targets for receptor-mediated nanoparticle delivery
Identification of novel breast and ovarian cancer susceptibility genes by hypothesis-driven and exome-wide approaches